Myelin loss associated with neuroinflammation in hypertensive rats

Stroke

Volumn 43, Issue 4, 2012, Pages 1115-1122

  Jalal, Fakhreya Y ^a   Yang, Yi ^a   Thompson, Jeffrey ^a   Lopez, Anita C ^a   Rosenberg, Gary A ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

matrix metalloproteinases; vascular cognitive impairment; white matter

Indexed keywords

CASPASE 3; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; BIOCHEMISTRY; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMYELINATION; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HYPERTENSION; IMMUNOBLOTTING; MALE; MAZE TEST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; WHITE MATTER;

ANIMALS; APOPTOSIS; ASTROCYTES; BLOOD-BRAIN BARRIER; CASPASE 3; CEREBRAL CORTEX; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICROGLIA; MYELIN BASIC PROTEINS; MYELIN SHEATH; RATS; RATS, INBRED SHR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859361122     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.643080     Document Type: Article

References (31)

1. Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull. 2007;83:291-305 (Pubitemid 47614262)
2. Chui H. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone. 2001;3:40-51
3. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241 (Pubitemid 44337162)
4. Tekkök SB, Ye Z, Ransom BR. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab. 2007;27: 1540-1552 (Pubitemid 47301441)
5. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis. 2002;13 Suppl 2:7-10 (Pubitemid 34233902)
6. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab. 2008;28:1877-1891
7. Yang Y, Jalal FY, Thompson JF, Walker EJ, Candelario-Jalil E, Li L, et al. Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-/TACE in focal cerebral ischemia in mice. J Neuroinflammation. 2011;8:108
8. Walker EJ, Rosenberg GA. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res. 2010;88:764-773
9. Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke. 2001;32: 1162-1168
10. Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, et al. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke. 2011;42:2158-2163
11. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry. 2010;81:192-197
12. Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke. 2011;42:1345-1350
13. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27: 697-709 (Pubitemid 46474608)
14. Bauer AT, Bürgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30:837-848
15. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724-7732 (Pubitemid 32904971)
16. Masumura M, Hata R, Nagai Y, Sawada T. Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci Res. 2001;39:401-412 (Pubitemid 32215422)
17. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol. 1994;87: 484-492 (Pubitemid 24128976)
18. Guerrini U, Sironi L, Tremoli E, Cimino M, Pollo B, Calvio AM, et al. New insights into brain damage in stroke-prone rats: A nuclear magnetic imaging study. Stroke. 2002;33:825-830 (Pubitemid 34204012)
19. Sood R, Taheri S, Estrada EY, Rosenberg GA. Quantitative evaluation of the effect of propylene glycol on BBB permeability. J Magn Reson Imaging. 2007;25:39-47 (Pubitemid 46095199)
20. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47-60 (Pubitemid 14088970)
21. Sood R, Yang Y, Taheri S, Candelario-Jalil E, Estrada EY, Walker EJ, et al. Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats. J Cereb Blood Flow Metab. 2009;29:308-316
22. Folkow B, Gurévich M, Hallbäck M, Lundgren Y, Weiss L. The hemodynamic consequences of regional hypotension in spontaneously hypertensive and normotensive rats. Acta Physiol Scand. 1971;82:9A-10A
23. Chen J, Cui X, Zacharek A, Cui Y, Roberts C, Chopp M. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke. 2011;42:445-452
24. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kövari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain. 2007;130:2830-2836 (Pubitemid 350033968)
25. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197-2204 (Pubitemid 350294674)
26. Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004;35: e159-e162
27. Goldberg MP, Ransom BR. New light on white matter. Stroke. 2003;34: 330-332 (Pubitemid 36206313)
28. Jamin N, Junier MP, Grannec G, Cadusseau J. Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain. Exp Neurol. 2001;172:17-28 (Pubitemid 33141151)
29. Kim YS, Kim SS, Cho JJ, Choi DH, Hwang O, Shin DH, et al. Matrix metalloproteinase-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci. 2005;25:3701-3711
30. Choi DH, Kim EM, Son HJ, Joh TH, Kim YS, Kim D, et al. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem. 2008;106:405-415 (Pubitemid 351840221)
31. D'Souza CA, Mak B, Moscarello MA. The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease. J Biol Chem. 2002;277:13589-13596. (Pubitemid 34967957)